Silexion Therapeutics GAAP EPS of -$2.88
Source: SeekingAlpha
2025-11-12 10:45:39 ET
More on Silexion Therapeutics
- Seeking Alpha’s Quant Rating on Silexion Therapeutics
- Historical earnings data for Silexion Therapeutics
- Financial information for Silexion Therapeutics
Read the full article on Seeking Alpha
For further details see:
Silexion Therapeutics GAAP EPS of -$2.88
Silexion Therapeutics Corp
NASDAQ: SLXN
SLXN Trading
8.47% G/L:
$1.92 Last:
29,366 Volume:
$1.95 Open:
SLXN Latest News
March 05, 2026 08:00:00 am
Silexion Therapeutics Urges Shareholders to Vote Ahead of March 16 Extraordinary General Meeting
January 21, 2026 08:30:00 am
Silexion Therapeutics to Attend 7th Annual RNAi-Based Therapeutics Summit
SLXN Stock Data
$5,158,959
2,939,043
62.46%
9
N/A
Biotechnology & Life Sciences
Healthcare
US
Ramat-Gan
